SCHEMBL6804044

SCHEMBL6804044

COc1cccc2c1CC[C]2O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
TP53 P04637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP19A1 P11511 1/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798725 0.89 ABCB1 (0.47) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL165220 0.77 KDM4E (0.61) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL29506042 0.77 KDM4E (0.61) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL166262 0.77 BRAF (0.51) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL166263 0.77 BRAF (0.51) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL15395885 0.74 ACHE (0.44) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL10599410 0.74 MAPT (0.47) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL20205516 0.73 DRD2 (0.44) ACHENPC1RAB9AKDM4ELMNA
SCHEMBL868653 0.73 CA1 (0.59) ACHECYP19A1CA1CA2CA4
SCHEMBL3013079 0.72 CYP19A1 (0.50) ACHENPC1RAB9AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6750243-B1 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis AstraZeneća AB (SE) 2004-06-15 US claimed